+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Dual Energy Ct for Monitoring Targeted Therapies in Patients with Advanced Gastrointestinal Stromal Tumor: Initial Results



Dual Energy Ct for Monitoring Targeted Therapies in Patients with Advanced Gastrointestinal Stromal Tumor: Initial Results



Current Pharmaceutical Biotechnology 12(4): 547-557




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 068055326

Download citation: RISBibTeXText

DOI: 10.2174/138920111795164066


Related references

Dual energy CT for monitoring targeted therapies in patients with advanced gastrointestinal stromal tumor: initial results. Current Pharmaceutical Biotechnology 12(4): 547-557, 2011

Monitoring the effect of targeted therapies in a gastrointestinal stromal tumor xenograft using a clinical PET/CT. Molecular Imaging and Biology 13(6): 1234-1240, 2012

Surgical treatment for patients with advanced gastrointestinal stromal tumor after targeted therapy. Zhonghua Wei Chang Wai Ke Za Zhi 12(2): 155-158, 2010

CT-based response assessment of advanced gastrointestinal stromal tumor: dual energy CT provides a more predictive imaging biomarker of clinical benefit than RECIST or Choi criteria. European Journal of Radiology 82(6): 923-928, 2014

Objective and subjective image quality of liver parenchyma and hepatic metastases with virtual monoenergetic dual-source dual-energy CT reconstructions: an analysis in patients with gastrointestinal stromal tumor. Academic Radiology 21(4): 514-522, 2014

The benefit of using CT-perfusion imaging for reliable response monitoring in patients with gastrointestinal stromal tumor (GIST) undergoing treatment with novel targeted agents. Acta Radiologica 54(7): 711-721, 2013

Sunitinib in pediatric patients with advanced gastrointestinal stromal tumor: results from a phase I/II trial. Cancer ChemoTherapy and Pharmacology 2019, 2019

Liver transplantation for metastatic wild-type gastrointestinal stromal tumor in the era of molecular targeted therapies: Report of a first case. American Journal of Transplantation 2019, 2019

Gastrointestinal stromal tumors A model for understanding solid tumor biology and development of targeted therapies, or just another low-hanging fruit?. Asia-Pacific Journal of Clinical Oncology 4(4): 185-187, 2008

Treatment of advanced gastrointestinal stromal tumor: a marriage of targeted therapy and surgery?. Annals of Surgical Oncology 14(1): 1-2, 2006

Lancet in the era of targeted drug therapy: the role of surgery in the management of advanced gastrointestinal stromal tumor. Zhonghua Wei Chang Wai Ke Za Zhi 19(11): 1211-1216, 2018

FDG-avid thyroid incidentaloma in advanced gastrointestinal stromal tumor: metachronous dual primaries. Indian Journal of Gastroenterology 26(3): 146-147, 2007

How to decide whether to offer and use "nonstandard" therapies in patients with advanced sarcomas and gastrointestinal stromal tumors: global variations in clinical practice, assessment, and access to therapies in diseases with limited incidence and data. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting 2012: 645-650, 2012

Implications of mutational analysis for the management of patients with gastrointestinal stromal tumors and the application of targeted therapies. Cancer Investigation 28(8): 839-848, 2010

Gastrointestinal Stromal Tumor of the Jejunum With Active Bleeding Demonstrated on Dual-Energy MDCT Angiography: A Case Report. Current Problems in Diagnostic Radiology 2017, 2017